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Background: Recent reports support a novel biological phenomenon about cancer related neurogenesis. However,
little is known about the clinicopathological significance of neurogenesis in breast cancer.
Methods: A total of 196 cases, including 20 of normal tissue, 14 of fibroadenoma, 18 of ductal carcinoma in situ
(DCIS) and 144 of invasive ductal carcinoma (IDC) of the breast were used. The tissue slides were immunostained
for protein gene product (PGP) 9.5 and S 100 to identify nerves. The correlation between the expression of PGP 9.5
and clinicopathological characteristics in IDC of the breast was assessed.
Results: While the PGP 9.5 positive nerve fibers are identified in all cases of normal breast tissue controls and in the
tumor stroma of 61% (89/144) cases of invasive ductal carcinomas, PGP 9.5 positive nerve fibers are not seen in the
tumor stroma of cases of fibroadenoma and DCIS. The percentage of tumors that exhibited neurogenesis increased
from tumor grade I to tumor grade II and III (29.4% vs 71.8%, p < 0.0001). In addition, patients with less than 3 years
of disease-free survival tended to have a higher positive expression of PGP 9.5 compared to patients with an equal
or more than 3 years of disease-free survival (64.8% vs 46.7%, p = 0.035). Furthermore, moderate/strong expression
of PGP 9.5 was found to be significantly related to microvessel density (MVD, p = 0.014). Interestingly, PGP 9.5
expression was significantly associated with higher MVD in the ER-negative (p = 0.045) and node-negative
(p = 0.039) subgroups of IDC of the breast.
Conclusions: This data indicates that neurogenesis is associated with some aggressive features of IDC including
tumor grade and patient survival as well as angiogenesis, especially in ER-negative and node-negative subtypes of
IDC of the breast. Thus, neurogenesis appears to be associated with breast cancer progression and may play a role
in therapeutic guidance for patients with ER-negative and node-negative invasive breast cancer.
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Tumor-stromal interactions are critical to cancer develop-
ment. For example, angiogenesis, inflammation, matrix re-
modeling and perineural invasion (PNI). It is well known
that PNI is a poor prognostic factor in malignancies like
prostate [1], head and neck [2], and pancreatic cancer [3].
However, recent reports have described a novel biological* Correspondence: hxhan2004@hotmail.com; ghzhang2009@shsmu.edu.cn
†Equal contributors
1Department of Pathology, Shanghai Third People’s Hospital, Shanghai
Jiaotong University School of Medicine, 280 Mohe Road, Shanghai 201999,
China
3Department of Physiology, Shanghai Jiaotong University School of
Medicine, 280 South Chongqing Road, Shanghai 200025, China
Full list of author information is available at the end of the article
© 2014 Zhao et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orphenomenon that active neurogenesis occurs in cancer,
which indicates specific interactions between cancer cells
and the existence of nerve fibers other than PNI [4-6].
Entschladen F et al proposed the hypothesis that tu-
mors may initiate their own innervation by the release
of neurotrophic factors similar to that of angiogenesis
[7]. It is likely that tumor neurogenesis is related to me-
tastasis, since the ingrown nerve endings can release
neurotransmitters which enhance the metastasis devel-
opment. Ayala GE et al first described cancer-related
neurogenesis and its putative regulatory mechanism in
prostate cancer. This study provides strong evidence that
neurogenesis does occur in prostate cancer and increased
nerve density has been found in tumors compared withtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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ported that neurogenesis in colorectal cancer appeared
to play a critical role in colorectal cancer progression
[5]. Accumulating evidence indicates that neuronal system-
dependent facilitation of tumor angiogenesis and tumor
growth by calcitonin gene-related peptide [8] or nerve
growth factor [9] occurred in breast cancer. However, the
role of neurogenesis in breast cancer is unclear.
We hypothesize that neurogenesis is important in
breast cancer progression. Therefore, we investigated
whether neurogenesis occurs in breast cancer, if so; we
evaluated its clinicopathological significance.
Methods
Clinical specimens
One hundred and ninety-six cases were retrieved from
the files of the Departments of Pathology in Shanghai
Third People's Hospital, Shanghai Jiaotong University
School of Medicine and Shanghai First Maternity and
Infant Healthy Hospital, Tongji University. The most
histological type was invasive ductal carcinoma (144
cases), followed by ductal carcinoma in situ (DCIS, 18
cases), fibroadenoma (14 cases) and then normal breast
tissue (20 cases). The pathological parameters, including
tumor size, differentiation and the presence of nodal
metastasis, were carefully reviewed. The histological
grade and stage were evaluated by a modified Bloom-
Richardson grading system and American Joint Committee
on Cancer (AJCC), respectively. Out of 144 invasive
ductal carcinoma (age range = 32-71 years; average age
= 48.06 years), 62.5% (90/144) were equal to/more than
3 years of disease free survival. All the patients with
IDC received adjuvant therapy. In addition, the patients
with distant metastasis were not enrolled in this study.
One representative paraffin block from each case was
used for the study. The study was approved by the Ethical
Review Boards of Shanghai Third People's Hospital,
Shanghai Jiaotong University School of Medicine and
Shanghai First Maternity and Infant Healthy Hospital,
Tongji University. No consent from patients involved in
this study was needed because the required consent was
waived by Ethical Review Boards. The information
about patients involved in this study is kept confidential
at all times.
Immunohistochemistry
Immunohistochemical assays were performed on formalin-
fixed paraffin-embedded tissues. Sections (5 μm thick)
were cut, deparaffinized in xylene and rehydrated in
graded alcohols. Slides were boiled in citrate buffer
(pH 6.0) at 95 ~ 100°C for 5 minutes and were cooled
for 20 minutes. Endogenous peroxide was blocked by
3% hydrogen peroxide in methanol for 10 minutes. Sec-
tions were incubated with rabbit anti-human PGP 9.5(1:500, DAKO, Carpinteria, CA, USA), rabbit anti-human
S100 (1:200, DAKO, Carpinteria, CA, USA) and mouse
anti-human CD34 antibodies overnight at 4°C. Immuno-
histochemical staining was performed using EnVision +
HRP DAB system (DAKOCytomation, Carpinteria, CA,
USA). All sections were counterstained with Meyer’s
Hematoxylin. The sections processed without the pri-
mary antibodies were used as negative control.
Interpretation of immunohistochemical staining
A pathologist read all immunostained slides. Each slide
was marked at points in which positive PGP 9.5/S100
immunostaining was shown. A single digital image was
created with the Olympus BLISS HD virtual microscopy
system at × 400 magnification. The diameters of nerve
fascicles were measured with the Optimas 6 Image Ana-
lysis Suite (Optimas Corp.) Most of the diameters of
nerve fascicles were less than 100 μm (94.7%). Nerve
density was evaluated by counting the number of nerve
fascicles with diameters of < 100 μm in 20 continuous
fields at × 200 magnification. Nerve density results were
grouped into 3 categories: 1) negative, no nerve fascicles
or nerve fibers, 2) weak expression, 1 to 10 nerve fasci-
cles, and 3) moderate/strong expression, > 10 nerves fas-
cicles. Intratumoral microvessel density (MVD) was
recorded by counting CD34-positive vessels in the most
vascularized area in four × 200 fields [10]. Blood vessels
with a lumen diameter exceeding approximately eight
red blood cells were excluded. For estrogen receptor
(ER) and progesterone receptor (PR), we defined cases
with more than 5% positive tumor cells of moderate in-
tensity as positive. Immunohistochemistry results were
analyzed by three independent pathologists under a mul-
tihead microscope in cases of disagreement.
Statistical analysis
All statistical analyses were carried out using SPSS soft-
ware (SPSS Ver. 11.0, USA). Some data was presented as
absolute numbers and percentages, other data was pre-
sented as mean ± SD. χ2-test was used to examine the
association between PGP 9.5 expression and the various
clinicopathological characteristics. The relationship be-
tween PGP 9.5 expression and MVD was evaluated using
the Mann-Whitney test. Reported P-values less than 0.05
were considered as significant.
Results
Neurogenesis in breast cancer
PGP 9.5 or S100 expression was identified in normal
breast tissue control cases and in high percentage of
breast cancer cases. The pattern of neurogenesis in IDC
was shown in Figure 1. In the most of cases the frag-
mented nerve fascicles were distributed in the tumor
stroma. In some cases, the scattered fine nerve fibers
Figure 1 Photomicrograph representatives of nerves in normal breast tissue (A, PGP 9.5 expression) and in invasive ductal carcinoma
of the breast (B-E, PGP 9.5 expression; F, S 100 expression). The scattered fine nerve fibers were seen in the stroma (B-C) and most of them
surrounded the blood vessels (B). Some fine nerve fibers were sporadically located among the cancer cells (D), the high-magnification view of
the area in the box in photomicrograph D is the fine nerve fibers. In most of the cases the fragmented nerve fascicles were distributed in the
stroma of tumor (E-F).
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some fine nerve fibers were sporadically located around
the cancer cells. Nerve fibres were found in all the normal
breast tissue control cases. However, there is no PGP 9.5
positive nerve fiber identified in the stroma of cases of
fibroadenoma and DCIS. Overall, 61.8% (89/144) of inva-
sive ductal carcinoma cases exhibited evidence of neuro-
genesis. PGP 9.5 positive nerve fibers were observed in
all normal breast tissue controls (Table 1). There is noTable 1 PGP 9.5 expression in different histological types of t
PGP 9.5 expression





IDC Invasive ductal carcinoma, DCIS Ductal carcinoma in situ.difference in diameters of the nerve fibers between nor-
mal breast tissue control (23.4 ± 8.2 μm) and in invasive
ductal carcinomas (20.8 ± 10.4 μm).
The relationship between neurogenesis and
clinicopathological characteristics in IDC of the breast
While analyzing invasive ductal carcinomas of different
MBR grade, we found that PGP 9.5 positive rate was
29.4% (10/34) in grade I cases, but PGP 9.5 positive ratehe breast





Table 3 Relationship between the PGP 9.5 expression and
microvessel density (MVD) according to the estrogen
receptor status and lymph node involvement in invasive
ductal carcinoma of the breast
No. cases MVD P value
PGP 9.5 expression total P = 0.014
Weak 54 37.15 ± 10.30
Moderate/strong 35 43.11 ± 11.30
ER-positive P = 0.148
Weak 27 38.22 ± 10.64
Moderate/strong 15 43.40 ± 11.33
ER-negative P = 0.045
Weak 27 36.07 ± 10.03
Moderate/strong 20 42.90 ± 11.56
LN-positive P = 0.162
Weak 24 39.13 ± 8.53
Moderage/strong 18 43.56 ± 11.63
LN-negative P = 0.039
Weak 30 35.37 ± 11.02
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ence was statistically significant (p < 0.0001). The PGP
9.5 positive rate was significantly higher in cases of less
than 3 years of disease-free survival (64.8%, 35/54) com-
pared to cases of equal or more than 3 years of disease-free
survival (46.7%, 42/90; p = 0.035). However, no significant
difference in PGP 9.5 expression was found between tumor
groups of different stage (stage I: 56.5%; stage II: 63.5%;
stage III: 61.8%). Likewise, no significant difference of PGP
9.5 expression was found in cases of different lymph node,
ER and PR status (Table 2).
The relationship between neurogenesis and angiogenesis
in IDC of the breast
As shown in Table 3, moderate/strong PGP 9.5 expression
(more than 10 nerves) was found to be significantly re-
lated with tumor MVD (p = 0.014). Intriguingly, analysis
of subgroups of ER and node status revealed that moder-
ate/strong expression of PGP 9.5 was significantly associ-
ated with higher MVD in the ER-negative (p = 0.045)
and node-negative (p = 0.039) subgroups. No significantTable 2 Relationship between clinicopathological data
and PGP 9.5 expression in invasive ductal carcinoma of
the breast
PGP 9.5 expression
No. case Negative Positive P-value
Tumor size P = 0.319
≤ 2 cm 86 30 (34.9%) 56 (65.1%)
> 2 cm 58 25 (43.1%) 33 (56.9%)
Tumor grade P < 0.0001
I 34 24 (70.6%) 10 (29.4%)
II - III 110 31 (28.2%) 79 (71.8%)
Tumor stage P = 0.834
I 23 10 (43.5%) 13 (56.5%)
II 74 27 (36.5%) 47 (63.5%)
III 47 18 (38.2%) 29 (61.8%)
LN metastasis P = 0.825
Negative 75 28 (37.3%) 47 (62.7%)
Positive 69 27 (39.1%) 42 (60.9%)
ER P = 0.399
Negative 80 33 (41.3%) 47 (58.8%)
Positive 64 22 (34.4%) 42 (65.6%)
PR P = 0.801
Negative 70 26 (37.1%) 44 (62.9%)
Positive 74 29 (39.2%) 45 (60.8%)
Disease free survival P = 0.035
< 3 years 54 19 (22.2%) 35 (64.8%)
≥ 3 years 90 48 (53.3%) 42 (46.7%)
LN Lymph node, ER Estrogen receptor, PR Progesterone receptor.
Moderate/strong 17 42.64 ± 11.27association was found between PGP 9.5 expression and
MVD in ER-positive and node-positive subgroups.
Discussion
Our data show that some degree of neurogenesis occurs
in the invasive ductal carcinoma when compared to fibro-
adenomas and DCIS. This indicates that cancer-related
neurogenesis does occur in breast cancer, which is similar
to previously reported observation that active neurogen-
esis occur in prostate cancer [4], colorectal cancer [5],
esophageal and cardiac carcinoma [11], tumors of the hu-
man urinary bladder [12] and choroidal melanoma [13].
Taken together, this novel phenomenon that cancer initi-
ates its own innervations may be universal.
Neuroepithelial interactions occur at several stages of
oncogenesis. PNI is the most obvious and well studied
[14,15]. Cancer-related neurogenesis most likely facili-
tates PNI, which would then become the second step of
neuroepithelial interactions in tumor. Understanding of
the cancer-related neurogenesis may be of help in devel-
oping cancer-related therapies in breast cancer.
Ayala and colleagues [4] recently reported that nerve
density in prostate tissues was higher in cancer and pre-
malignant specimens compared to normal prostate tis-
sues. Also, neurogenesis was correlated with features of
aggressive prostate cancer and with recurrence in pros-
tate cancer. In addition, Albo and colleagues [5] demon-
strated neurogenesis in colorectal cancer as a marker of
aggressive tumor behavior and poor outcomes. Our data
show that some degree of neurogenesis occurs in IDC,
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IDC of the breast, neurogenesis is correlated with tumor
grade and disease-free survival. This indicates that
neurogenesis is functionally significant in human disease
and involved in the progression of breast cancer.
The initial observation that a tumor stimulates and
nurtures the development of blood vessels for its own
nourishment was made over 30 years ago [16]. Since
then, a plethora of studies have unraveled the mecha-
nisms of this phenomenon called neoangiogenesis, and
several promising anti-angiogenic drugs have been de-
veloped [17]. In the last 10 years, several studies have
thoroughly demonstrated that vascules and neurons
share molecular tools and strategies during their net-
working [18-20]. Our data suggests a significant relation-
ship between neurogenesis and angiogenesis in breast
cancer. Interestingly, our study shows that higher nerve
density is significantly associated with MVD in ER-
negative and node-negative groups of IDC. These find-
ings may open a future direction for the targeted therapy
for these groups of ER negative and node-negative IDC.
Further studies will explore the mechanisms underlying
the interaction between neurogenesis and angiogenesis
in breast cancer.
Conclusions
This data indicates that neurogenesis is associated with
some aggressive features of IDC including tumor MBR
grade and patient survival. It is also associated with
tumor angiogenesis, particularly in the ER-negative and
node-negative subtypes of IDC. Thus, neurogenesis ap-
pears to be associated with breast cancer progression
and may play a role in therapeutic guidance for patients
with ER-negative and node-negative invasive breast
cancer.
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